MediWound Ltd. (MDWD)
12.87
-0.28
(-2.13%)
USD |
NASDAQ |
Oct 07, 16:00
12.87
0.00 (0.00%)
After-Hours: 20:00
MediWound Profit Margin (Quarterly) : -239.1% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -239.1% |
| March 31, 2026 | -200.1% |
| December 31, 2025 | -384.7% |
| September 30, 2025 | -48.85% |
| June 30, 2025 | -233.3% |
| March 31, 2025 | -18.36% |
| December 31, 2024 | -66.92% |
| September 30, 2024 | -236.1% |
| June 30, 2024 | -124.5% |
| March 31, 2024 | -196.0% |
| December 31, 2023 | -32.65% |
| September 30, 2023 | -45.98% |
| June 30, 2023 | 19.19% |
| March 31, 2023 | -97.21% |
| December 31, 2022 | -64.18% |
| September 30, 2022 | -72.36% |
| June 30, 2022 | -93.27% |
| March 31, 2022 | -81.44% |
| December 31, 2021 | -75.82% |
| September 30, 2021 | -52.50% |
| June 30, 2021 | -52.75% |
| March 31, 2021 | -48.76% |
| December 31, 2020 | -25.91% |
| September 30, 2020 | -30.04% |
| June 30, 2020 | -76.88% |
| Date | Value |
|---|---|
| March 31, 2020 | -55.45% |
| December 31, 2019 | -64.79% |
| September 30, 2019 | -57.67% |
| June 30, 2019 | 61.29% |
| March 31, 2019 | -902.4% |
| December 31, 2018 | |
| September 30, 2018 | -343.1% |
| June 30, 2018 | -404.0% |
| March 31, 2018 | -875.2% |
| December 31, 2017 | -425.1% |
| September 30, 2017 | -474.2% |
| June 30, 2017 | -649.5% |
| March 31, 2017 | -798.9% |
| December 31, 2016 | -438.6% |
| September 30, 2016 | -1.10K% |
| June 30, 2016 | -2.11K% |
| March 31, 2016 | -1.49K% |
| December 31, 2015 | -2.91K% |
| September 30, 2015 | -3.69K% |
| June 30, 2015 | -2.50K% |
| March 31, 2015 | -8.94K% |
| December 31, 2014 | -5.72K% |
| September 30, 2014 | -10.91K% |
| June 30, 2014 | -15.46K% |
| March 31, 2014 | -1.47K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | -13.88% |
| RedHill Biopharma Ltd. | -- |
| Purple Biotech Ltd. | -- |
| Sol-Gel Technologies Ltd. | -622.8% |
| PolyPid Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -52.83% |
| Return on Assets | -25.25% |
| Return on Invested Capital | -42.65% |
| Gross Profit Margin (Quarterly) | 10.90% |
| Operating Margin (Quarterly) | -305.9% |
| Return on Net Operating Assets | -60.10% |